期刊文献+

老年医院获得性肺炎病原学及药物敏感性分析 被引量:5

Pathogens and drug-susceptibility of hospital acquired pneumonia in elderly patients
下载PDF
导出
摘要 目的调查老年住院患者医院获得性肺炎(HAP)的病原学分布及药物敏感性,为临床治疗提供参考。方法回顾性分析2010年1月至2015年12月在首都医科大学附属北京友谊医院老年内科住院并诊断为HAP的老年患者的病原学及药物敏感性资料。结果共纳入600例老年HAP患者,占同期老年内科住院患者医院获得性感染的59.9%(600/1 001)。2010年至2015年老年HAP发生例数分别为60例、89例、75例、67例、155例和154例,晚发HAP占87.5%(525/600)。600例老年HAP患者中81.3%(488/600)病原学检查阳性,最常见的病原菌依次为铜绿假单胞菌(21.5%,105/488)、鲍曼不动杆菌(21.3%,104/488)、金黄色葡萄球菌(17.2%,84/488)、白色念珠菌(10.5%,51/488)和肺炎克雷伯杆菌(5.1%,25/488)。铜绿假单胞菌对氨基糖甙类抗生素的敏感率最高(83.2%~95.5%),哌拉西林/他唑巴坦次之(79.3%),对美罗培南和亚胺培南的敏感率仅为54.5%和52.6%。鲍曼不动杆菌几乎对所有常用抗菌药物的敏感率均低于50%,对亚胺培南耐药率高达84.3%。肺炎克雷伯菌对亚胺培南、阿米卡星和头孢替坦敏感率高于80%,对其他抗菌药物敏感率均低于80%。耐甲氧西林金黄色葡萄球菌占金黄色葡萄球菌的85.7%(72/84),对万古霉素、利奈唑胺、奎奴普丁/达福普汀和替加环素100%敏感。结论 HAP是老年住院患者最常见的医院获得性感染。老年HAP患者最常见的分离菌是铜绿假单胞菌、鲍曼不动杆菌、金黄色葡萄球菌、白色念珠菌和肺炎克雷伯菌。老年HA P常见致病菌多重耐药情况严重,需引起关注。 Objective To investigate the pathogens and drug - susceptibility of hospital acquired pneumonia (HAP) in elderly inpatients so as to provide reference for clinical management. Methods Pathogens and drug - susceptibility of hospital acquired pneumonia in elderly patients hospitalized in the department of geriatric medicine, Beijing Friendship Hospital from January 2010 to December 2015 were investigated retrospectively. Results Six hundred elderly cases with HAP were enrolled in this study, with a ratio of 59.9% of all hospital acquired infections in the department of geriatric medicine during the period of 2010 to 2015. The nulnbers of elderly HAP cases were 60,89,75,67, 155 and 154 case from 2010 to 2015 respectively. Late - onset HAP was in the majority of the overall cases(87.5% , 525/600). Pathogens were identified in 488 cases ( 81.3 % ) , including pseudomonas aeruginosa (21.5 % , 105/488 ) , Acinetobacter baumannii (21.3 % , 104/488 ) , Staphylococcus aureus ( 17.2% , 84/488) , Candida albicans ( 10.5% , 51/488 ) and Klebsiella pneumonia (5.1% , 25/488 ) , which were the most common pathogens. The susceptibility of P. aeruginosa to aminoglycoside antibiotics were the highest ( 83.2% - 95.5 % ), then was piperacillin/tazobactam (79.3%). The susceptibility of P. aeruginosa to meropenem and imipenem were 54.5% and 52.6% respectively. A. baumannii showed low susceptibility of less than 50% to almost all kinds of antibiotics, with a high resistance rate of 84.3% to imipenem. K. pneumonia showed a high susceptibility of more than 80% to imipenem, amikacin and cefotetan, and low susceptibility of less than 80% to all the other antibiotics. Methicillin - resistant Staphylococcus aureus (MRSA) accounted for 85.7% ( 72/84 ) in all isolated strains of S. aureus. The susceptibility of MRSA to vancomycin, linezolid, quinupristin/dalfopristin and tigecycline were all 100%. Conclusion HAP is the most common hospital acquired infection in elderly inpatients. The most frequently identified pathogens of elderly HAP are p. aeruginosa, A. baumannii, S. aureus, C. albicans and K. pneumonia. The frequent pathogens of elderly HAP show high resistance rates to antibiotics and should be payed more attention.
出处 《临床和实验医学杂志》 2016年第14期1380-1384,共5页 Journal of Clinical and Experimental Medicine
基金 首都医科大学基础-临床合作研究基金(12JL38)
关键词 老年患者 医院获得性肺炎 病原学 药物敏感性 Elderly patients Hospital acquired pneumonia Pathogens Drugsusceptibility
  • 相关文献

参考文献10

二级参考文献89

  • 1王豫平,王慕云,廖致红.多重耐药铜绿假单胞菌感染相关因素分析[J].中华医院感染学杂志,2006,16(9):1059-1060. 被引量:59
  • 2王辉,郭萍,孙宏莉,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中华检验医学杂志,2006,29(12):1066-1073. 被引量:237
  • 3王辉.老年患者医院感染相关因素调查分析[J].中华医院感染学杂志,2007,17(7):800-800. 被引量:19
  • 4刘坤,李有信,杜晓玲.耐万古霉素肠球菌医院感染危险因素分析[J].中华医院感染学杂志,2007,17(8):1000-1002. 被引量:17
  • 5Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med, 2002,165 : 867-903.
  • 6Fagon JY, Chastre J, Hance A J, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med, 1993,94:281-288.
  • 7Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of pneumonia in a large US database. Chest, 2002,122 : 2115-2121.
  • 8Safdar N, Dezfulian C, Collard HR, et al. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med, 2005, 33 : 2184-2193.
  • 9Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest, 1997, 111: 676-685.
  • 10Horan TC, Gaynes RP. Surveillance of nosocomial infections. In : Hospital Epidemiology and Infection Control, 3rd ed. Mayhall CG, editor. Philadelphia: Lippincott Williams & Wilkins, 2004: 1659-1702.

共引文献1248

同被引文献44

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部